Matters arising 1995, this problem has been rectified in data from Scottish GUM clinics. Scotland is now in a unique position in the UK, in that we now collect statistics on individuals (with all due attention to preserving anonymity, by using unique identifiers), rather than diagnostic events. These changes have been introduced in tandem with a major review of case definitions and more clinically relevant coding categories.
Urinary symptoms, sexual intercourse and significant bacteriuria in male patients attending STD clinics
We read with interest the recent paper by David et all on urinary symptoms and bacteriuria among male STD clinic attenders. The authors state that urethritis and UTI cannot be distinguished on clinical grounds andlor urethral smears. We were surprised that no mention was made of the "two glass urine test" as a means of distinguishing pure urethritis from a combined urethritis/cystitis. We find this a useful test-from January to July this year 11 men attended our department with a documented UTI; nine of these had a cloudy second catch urine (not due to phosphaturia). We 
Epidemiology of gonococcal and chlamydial infections in Harrow and

Brent
Matondo and colleagues report on gonococcal and chlamydial infections in Harrow and Brent.' I would agree that it is important to perform such work since it can define "the extent of the problem in the community" and allow for the development of "a profile of STDs in our catchment population". Sadly, they have done neither of these two since their sampling is limited solely to those using the genitourinary medicine (GUM) (1 -6%) of the total would remain infected after treatment if a policy of test of cure for asymptomatic men were not followed; a more meaningful statistic. As Carne himself points out in the article, the cost of identifying each of these very small numbers of cases in America was estimated to be in the range $4900 to $109 800 per case. It might therefore be argued that a more cost effective use of this money would be to
